QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 专题：复旦大学上海医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 ARE/SUZ12 dual specifically-regulated adenoviral TK/GCV system for CML blast crisis cells 期刊论文 JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2015, 卷号: 34 作者:  Zu, Bailing;  Shi, Yi;  Xu, Min;  You, Guoling;  Huang, Zhenglan 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19 Suicide gene  Gene therapy  Chronic myelogenous leukemia  Blast crisis  Gene regulation   Cost-Effectiveness Study Comparing Imatinib with Interferon-alpha for Patients with Newly Diagnosed Chronic-Phase (CP) Chronic Myeloid Leukemia (CML) from the Chinese Public Health-Care System Perspective (CPHSP) 期刊论文 VALUE IN HEALTH, 2009, 卷号: 12 作者:  Chen, Zi;  Wang, Chun;  Xu, Xiaoping;  Feng, Weiwei 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19 China  CML  cost-effectiveness  imatinib   Imatinib is cost-effective comparing to interferon-(IFN) for patients with newly diagnosed chronic-phase (CP) chronic myeloid leukemia (CML) from the chinese public healthcare system perspective. 会议论文 作者:  Wang, Chun;  Chen, Zi;  Feng, Weiwei 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/19 Imatinib versus interferon-alpha (IFN) for patients with newly diagnosed chronic-phase (CP) chronic myeloid leukemia (CML) from the chinese public healthcare system perspective: 12 months cost and cost per responder analyses. 会议论文 作者:  Wang, Chun;  Chen, Zi;  Feng, Weiwei 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/19